Matching articles for "Visby Medical Women’s Sexual Health Test"

In Brief: A Home Test for Chlamydia, Gonorrhea, and Trichomoniasis

   
The Medical Letter on Drugs and Therapeutics • May 12, 2025;  (Issue 1728)
The FDA has authorized use of the Visby Medical Women's Sexual Health Test (Visby), an at-home test available without a prescription, for detection of Chlamydia trachomatis, Neisseria gonorrhoeae,...
The FDA has authorized use of the Visby Medical Women's Sexual Health Test (Visby), an at-home test available without a prescription, for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections in women with and without symptoms. It is the first test to become available in the US for these sexually transmitted infections (STIs) that can be performed entirely at home. Other at-home tests are available in the US for diagnosis of chlamydia, gonorrhea, and trichomoniaisis, but they require mailing a urine or blood sample to a laboratory. Chlamydia, gonorrhea, and trichomoniasis are the 3 most common STIs in the US.
Med Lett Drugs Ther. 2025 May 12;67(1728):80 | Show Full IntroductionHide Full Introduction